Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study

The worldwide health emergency of the SARS-CoV-2 pandemic and the absence of a specific treatment for this new coronavirus have led to the use of computational strategies (drug repositioning) to search for treatments. The aim of this work is to identify FDA (Food and Drug Administration)-approved dr...

Full description

Bibliographic Details
Main Authors: Gema Lizbeth Ramírez-Salinas, Marlet Martínez-Archundia, José Correa-Basurto, Jazmín García-Machorro
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Molecules
Subjects:
SARS-CoV-2
COVID-19
docking studies
FDA-approved drugs
spike glycoprotein
Online Access:https://www.mdpi.com/1420-3049/25/23/5615

Similar Items

Similar Items